Le Lézard
Classified in: Health, Business
Subjects: LIC, FDA

TYBER MEDICAL GAINS FDA AND MDR CLEARANCE FOR ITS IMPLANTABLE K-WIRES AND STEINMANN PINS IN STAINLESS STEEL AND TITANIUM ALLOY


BETHLEHEM, Pa., Sept. 21, 2023 /PRNewswire/ -- Tyber Medical, a leader in the medical device industry, is pleased to announce that it has received:

"Our customers now have instant access to nearly every type of implantable K-Wire or Steinmann Pin on the market."

These critical approvals pave the way for significant expansion and greater product availability for patients and Tyber's private-label partners.

"Our focus has always been on developing products that are innovative, efficient, and deliver unparalleled performance," said Jeff Tyber, CEO of Tyber Medical. "Receiving the FDA and MDR clearance for these platforms is a testament to our rigorous pursuit of advancing patient care while helping our customers expand their brand."

The cleared K-Wires and Steinmann Pins are available both Sterile and Non-Sterile and come in multiple configurations, including combinations of Trocar Tip, Diamond Tip, Fluted Tip, Partial Thread, Full Thread, Ball End, and Flat End options, making them versatile for multiple medical needs. Available in lengths ranging from 60mm to 450mm and diameters between 0.6mm and 6.35mm, these wires and pins provide comprehensive solutions for healthcare professionals.

David Hannah, CTO of Tyber Medical, added, "With this clearance, our customers now have instant access to nearly every type of implantable K-Wire or Steinmann Pin that exists on the market, and we're not even finished with this product line yet."

In a strategic move to extend its reach globally, Tyber Medical also obtained a reusable indication for its K-Wires in Europe thanks to its recent acquisition of ADSM-Synchro Medical. This acquisition marked another significant milestone for the company, further bolstering its global presence.

Commenting on the European expansion, Luigi Bivi, President of ADSM SAS (Tyber Medical France), stated, "This development is a key component of our strategic initiative to provide advanced medical solutions worldwide. Tyber Medical's sterile packed reusable platform in Europe enhances our capabilities and allows us to better serve high quality standards while maintaining a cost-effective approach to our product offering."

Tyber Medical continues to innovate and push boundaries in the medical device industry, constantly striving to provide cutting-edge solutions that redefine patient care.

About Tyber Medical

Tyber Medical LLC, is a leading orthopedic device manufacturer providing rapid access to FDA-cleared and CE-marked private label, portfolio-enhancing, regulatory-approved orthopedic implants for the spinal, extremity and trauma markets. Tyber Medical provides customers with a quick and seamless path to market. Since it was founded in 2012, the company has released more than 50 spine, extremity, and trauma systems. Tyber Medical aims to develop and utilize differentiated technologies to make advanced orthopedic implants. For more information, visit www.tybermedical.com.

For press inquiries, please contact:

Chandler Kline

Product Manager

[email protected]

717-333-0072

SOURCE Tyber Medical


These press releases may also interest you

at 06:55
KKR & Co. Inc. today reported its first quarter 2024 results, which have been posted to the Investor Center section of KKR's website at https://ir.kkr.com/events-presentations/. A conference call to discuss KKR's financial results will be held...

at 06:50
Brookfield Infrastructure Partners L.P. (Brookfield Infrastructure, BIP, or the Partnership) today announced its results for the first quarter ended March 31, 2024. "The benefits of inflation indexation, better than expected economic activity and...

at 06:50
OneSpaWorld Holdings Limited ("OneSpaWorld," or the "Company"), the pre-eminent global provider of health and wellness services and products on-board cruise ships and in destination resorts around the world, today announced financial results for the...

at 06:50
Pfizer Inc. reported financial results for the first quarter of 2024 and raised its Adjusted(3) diluted EPS guidance while maintaining all other components of its 2024 financial guidance(6). The first-quarter 2024 earnings presentation and...

at 06:50
The Estée Lauder Companies Inc. today reported net sales of $3.94 billion for its third quarter ended March 31, 2024, an increase of 5% from $3.75 billion in the prior-year period. Organic net sales increased 6% primarily due to double-digit growth...

at 06:45
Independence Contract Drilling, Inc. (the "Company" or "ICD") today reported financial results for the three months ended March 31, 2024. First quarter 2024 Highlights Net loss of $9.0 million, or $0.62 per shareAdjusted net loss, as defined below,...



News published on and distributed by: